Image: envato
The development of remdesivir as a treatment for COVID-19 was made possible by joint efforts between the pharmaceutical company Gilead and various US agencies. The US Army Medical Research Institute of Infectious Diseases successfully tested the drug in rhesus macaques, and after that, successful experiments in monkeys and mice were also carried out by the US National Institutes of Health (NIH). The FDA granted emergency authorization for the drug's use as a treatment for COVID-19 patients.
FBR SmartBrief
Translation: Let the Patients Live